Parvovirus B19- und Togavirus-assoziierte Arthritiden

Zusammenfassung

Zahlreiche Viren können akute und auch chronisch verlaufende Arthritiden auslösen oder auch andere entzündliche Gelenkerkrankungen in ihrem Verlauf beeinflussen. Neben den in eigenen Artikeln dieses Heftes behandelten Hepatitisviren und dem HIV sind hier insbesondere das humane Parvovirus B19 sowie die Familie der Togaviren mit dem Rötelnvirus sowie verschiedene Alphaviren zu nennen. Erwähnenswert, obwohl von untergeordneter Bedeutung, sind zudem die Erreger von Masern und Mumps. In dem Artikel werden Pathogenese, klinische Symptomatik und Diagnostik der von diesen Viren hervorgerufenen rheumatologischen Krankheitsbilder im Einzelnen besprochen.

Abstract

Several viruses are able to cause acute and chronic arthritides or may influence the clinical course of other inflammatory rheumatic diseases. Besides hepatitis viruses and HIV which will be discussed in other articles of this journal, parvovirus B19 and the members of the family of togaviridae, rubella virus and alpha viruses, are of special rheumatologic interest. Noteworthy, although less important, are arthritides caused by measles and mumps viruses. In this article, we describe the pathogenesis, clinical picture, and diagnosis of the rheumatologic syndromes caused by these viruses.

Literatur

• 1 Altschuler E L. Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning.  Lancet. 1999;  354 1026-1027
• 2 Anderson M J, Higgins P G, Davis L R. Experimental parvoviral infection in humans.  J Infect Dis. 1985;  152 257-265
• 3 Bengtsson A, Widell A, Elmstahl S. et al . No serologic indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19.  Ann Rheum Dis. 2000;  59 64-66
• 4 Benjamin C M, Chew G C, Silman A J. Joint and limb symptoms in children after immunization with measles, mumps and rubella vaccine.  BMJ. 1992;  304 1075-1078
• 5 Bosma T J, Etherington J, Best J M. Rubella virus and chronic joint disease: Is there an association?.  J clin Microbiol. 1998;  36 3524-3526
• 6 Cassinotti P, Bas S, Siegl G, Vischer T L. Association between human parvovirus B19 infection and arthritis.  Ann Rheum Dis. 1995;  54 498-500
• 7 Chang Y N, Kenan D J, Keene J D, Gatignol A, Jeang K T. Direct interactions between autoantigen La and human immunodeficiency virus leader RNA.  J Virol. 1994;  68 7008-7020
• 8 Chantler J K, Ford D K, Tingle A J. Persistent rubella infection and rubella-associated arthritis.  Lancet. 1982;  8285 1323-1325
• 9 Fawaz-Estrup F. Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus.  J Rheumatol. 1996;  23 1180-1185
• 10 Fraser J RE, Cunningham A L, Hayes K, Leach R, Lunt R. Rubella arthritis in adults: Isolation of virus, cytology and other aspects of the synovial reaction.  Clin Exp Rheumatol. 1983;  1 287
• 11 Frenkel L M, Nielson K, Cherry J D. et al . A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis.  Clin Infect Dis. 1996;  22 287-294
• 12 Gendi N ST, Gibson K, Wordsworth B P. Effect of HLA type and hypocomplementemia on the expression of parvovirus arthritis: one year follow-up of an outbreak.  Ann Rheum Dis. 1996;  55 63-65
• 13 Hahn H, Falk D, Kaufmann S HE, Ullmann U (Hrsg). Medizinische Mikrobiologie und Infektiologie. 4. Auflage. Springer-Verlag 2001
• 14 Harley D, Sleigh A, Ritchie S. Ross river virus transmission, infection, and disease.  Clin Microbiol Rev. 2001;  14 909-932
• 15 Howson C P, Howe C J, Fineberg H V. Adverse effects of pertussis and rubella vaccines: a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Devision of health promotion and disease prevention. Institute of Medicine, National Academy Press 1991
• 16 Hsu T C, Tsay G J. Human parvovirus B19 infection in patients with systemic lupus erythematosus.  Rheumatology. 2001;  40 152-157
• 17 Huppertz H I. How could infectious agents hide in synovial cells? Possible mechanisms of persistent viral infection in a model for the etiopathogenesis of chronic arthritis.  Rheumatol Int. 1994;  14 71-75
• 18 Ilonen J, Salmi A. Comparison of HLA-Dw1 and -Dw2 positive adherent cells in antigen presentation to heterozygous T-cell lines: a low rubella antigen-specific response associated with HLA-Dw2.  Human Immunol. 1986;  17 94-101
• 19 Kato S, Muranaka S, Takakura I, Kimura M, Tsuji K. HLA-DR antigens and the rubella-specific immune response in man.  Tissue Antigens. 1982;  19 140-145
• 20 Kelley W N, Harris E D, Ruddy S, Sledge C B. Textbook of Rheumatology. 5th Edition. Philadelphia, Pennsylvania; WB Saunders Company 1997: 2
• 21 Kerr J R, Cartron J P, Curran M D. et al . A study of the role of parvovirus B19 in rheumatoid arthritis.  Br J Rheumatol. 1995;  34 809-813
• 22 Kerr J R. Pathogenesis of human parvovirus B19 in rheumatic diseases.  Ann Rheum Dis. 2000;  59 672-683
• 23 Köhler W, Eggers H J, Fleischer B, Marre R, Pfister H, Pulverer G (Hrsg). Medizinische Mikrobiologie. 8. Auflage. München/Jena Urban & Fischer 2001
• 24 Laine M, Luukkainen R, Jalava J, Ilonen J, Kuusistö P, Toivanen A. Prolonged arthritis associated with Sindbis-related (Pogosta) virus infection.  Rheumatology. 2000;  19 1272-1274
• 25 Lio D, Caccamo N, D'Anna C, Cigna D, Candore G, Caruso C. Viral antibody titers are influenced by HLA-DR2 phenotype.  Exp Clin Immunogenet. 1994;  11 182-186
• 26 Lunardi C, Tiso M, Borgota L. et al . Chronic parvovirus B19 infection induces the production of antibodies with autoantigen binding properties.  Eur J Immunol. 1998;  28 936-948
• 27 Mitchell L A, Tingle A J, Grace M, Middleton P, Chalmers A C. Rubella virus vaccine associated arthropathy in postpartum immunized women: Influence of preimmunization serologic status on development of joint manifestations.  J Rheumatol. 2000;  27 418-423
• 28 Mitchell L A, Tingle A J, MacWilliam L, Horne C, Keown P, Gaur L K, Nepom G T. HLA-DR class II associations with rubella vaccine-induced joint manifestations.  J Infectious Dis. 1998;  177 5-12
• 29 Mitchell L A, Tingle A J, Shukin R, Sangeorzan J A, McCune J, Braun D K. Chronic rubella vaccine-associated arthropathy.  Arch Intern Med. 1993;  153 2268
• 30 Moore T L, Bandlamudi R, Alam S M. et al . Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population.  Semin Arthritis Rheum. 1999;  28 314-318
• 31 Moore T L. Parvovirus-associated arthritis.  Curr Opin Rheumatol. 2000;  12 289-294
• 32 Murai C, Munakata Y, Takahashi U. et al . Rheumatoid arthritis after human parvovirus B19 infection.  Ann Rheum Dis. 1999;  58 130-132
• 33 Murray P R, Baron E J, Pfaller M A, Tenover F C, Yolken R H. Manual of Clinical Microbiology. 7th Edition. American Society for Microbiology 1999
• 34 Nakhasi H L, Singh N K, Pogue G P, Cao X Q, Rouault T A. Identification and characterization of host factor interactions with cis-acting elements of rubella virus RNA.  Arch Virol. 1994;  9 255-267
• 35 Nesher G, Moore T L. Human parvovirus infection.  Infect Med. 1997;  14 638-642
• 36 Nesher G, Osborn T G, Moore T L. Parvovirus infection mimicking systemic lupus erythematosus.  Semin Arthritis Rheum. 1995;  24 297-303
• 37 Nussinoviten M, Harel L, Varsano I. Arthritis after mumps and measles vaccination.  Arch Dis Child. 1995;  72 348-349
• 38 Peltola H, Heinonen O P, Valle M. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program.  N Engl J Med. 1994;  331 1397-1402
• 39 Phillips P E. Viral arthritis.  Curr Opin Rheumatol. 1997;  9 337-344
• 40 Pogue G P, Hofmann J, Duncan R, Best J M, Etherington J, Sontheimer R D, Nakhasi L. Autoantigens interact with cis-acting elements of rubella virus RNA.  J Virol. 1996;  70 6269-6277
• 41 Pogue G P, Cao X Q, Singh N K, Nakhasi H L. 5'sequences of rubella virus RNA stimulate translation of chimeric RNAs and specifically interact with two host-encoded proteins.  J Virol. 1993;  67 7106-7117
• 42 Polk B F, Modlin J F, White J A, di Girolami P C. A controlled comparison of joint reactions among women receiving one of two rubella vaccines.  Am J Epidemiol. 1982;  115 19-25
• 43 Powers A M, Brault A C, Shirako Y, Strauss E G, Kang W, Strauss J H, Weavers S C. Evolutionary relationships and systematics of the alphaviruses.  J Virol. 2001;  75 10 118-10 131
• 44 Ray P, Black S, Shinefield J, Dillon A, Schwalbe J, Holmes S, Hadler S, Chen R, Cochi S, Wassilak S. Risk of chronic arthropathy among women after rubella vaccination.  JAMA. 1997;  278 551-556
• 45 Salmi A A. Measles Virus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (Eds) Manual of Clinical Microbiology. 7th Edition 73. American Society for Microbiology 1999: 951-957
• 46 Schnitzer T J, Penmetcha M. Viral Arthritis.  Curr Opinion Rheumatol. 1996;  8 341-345
• 47 Slater P E, Ben-Zvi T, Fogel A, Ehrenfeld M, Ever-Hadani S. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women.  Vaccine. 1995;  13 1529-1532
• 48 Soderlund M, von Essen R, Haapasaari J. et al . Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy.  Lancet. 1997;  349 1063-1065
• 49 Speyer I, Breedveld F C, Dijkmans B AC. Human parvovirus B19 infection is not followed by inflammatory joint disease during long-term follow-up: a retrospective study of 54 patients.  Clin Exp Rheumatol. 1998;  16 576-578
• 50 Stahl H D, Seidl B, Hubner B. et al . High incidence of parvovirus B19 DNA in synovial tissue of patients with undifferentiated mono- and oligoarthritis.  Clin Rheumatol. 2000;  19 281-286
• 51 Takahashi Y, Murai C, Shibata S. et al . Human parvovirus B19 as a causative agent for rheumatoid arthritis.  Proc Natl Acad Sci USA. 1998;  95 8227-8232
• 52 Tingle A J, Allen M, Petty R E, Kettyls G D, Chantler J K. Rubella-associated arthritis: comparative study of joint manifestations associated with natural rubella infection and RA27/3 rubella immunisation.  Ann Rheum Dis. 1986;  45 110-114
• 53 Tingle A J, Chantler J K, Pot K H, Paty D W, Ford D K. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.  J Infect Dis. 1985;  152 606-612
• 54 Tingle A J, Mitchell L A, Grace M, Middleton P, Mathias R, MacWilliam L, Chalmers A. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative woman.  Lancet. 1997;  349 1277-1281
• 55 Trapani S, Ermini M, Falcini F. Human parvovirus B19 infection: its relation with systemic lupus erythematosus.  Semin Arthritis Rheum. 1999;  28 319-325
• 56 Turunen M, Kuusisto P, Uggeldahl P E, Toivanen A. Pogosta disease: clinical observations during an outbreak in the province of North Karelia, Finland.  Br J Rheumatol. 1998;  37 1177-1180
• 57 Weibel R E, Benor D E. Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the national vaccine injury compensation program.  Arthritis & Rheumatism. 1996;  39 1529-1534
• 58 Woolf A D, Cohen B J. Parvovirus B19 and chronic arthritis: causal or casual association?.  Ann Rheum Dis. 1995;  54 535-536
• 59 Ytterberg S R. Viral arthritis.  Curr Opin Rheumatol. 1999;  11 275-280
• 60 Zhang D, Nikkari S, Vainionpaa R, Luukkainen R, Yli-Kerttula U, Toivanen P. Detection of rubella, mumps, and measles virus genomic RNA in cells from synovial fluid and peripheral blood in early rheumatoid arthritis.  J Rheumatol. 1997;  24 1260-1265